accelerated hypertension
Recently Published Documents


TOTAL DOCUMENTS

105
(FIVE YEARS 7)

H-INDEX

16
(FIVE YEARS 1)

2022 ◽  
Vol 4 ◽  
pp. 128-132 ◽  
Author(s):  
Manoj Kishor Patil

A 36-year-old man presented with Stage III accelerated hypertension and reluctance to start anti-hypertensive medication. This case is an attempt to demonstrate the importance of unconscious emotions and dreams with their psychodynamic correlations in essential hypertension through the portrait of disease. Mag carb was selected based on the totality of symptoms in view of the evolution of person, dispositions and adaptive patterns along with available physical characteristics through the psychodynamic study.


2021 ◽  
Vol 14 (1) ◽  
pp. e234686
Author(s):  
Sumanth Kollipara ◽  
Shruthi Ravindra ◽  
Kanthilatha Pai ◽  
Sahana Shetty

Conn’s syndrome is an important endocrine cause for secondary hypertension. Hypokalaemia paralysis and rhabdomyolysis with accelerated hypertension may be the presenting symptoms of Conn’s syndrome. Here, we present one such case of a 38-year-old woman presenting with accelerated hypertension and acute onset quadriplegia. On biochemical evaluation, she was found to have severe hypokalaemia, metabolic alkalosis and elevated creatinine phosphokinase. Further evaluation revealed an elevated aldosterone renin ratio suggestive of primary hyperaldosteronism which was localised to left adrenal adenoma on contrast-enhanced CT. Patient’s blood pressure and serum potassium levels normalised after resection of the adrenal adenoma.


2019 ◽  
Vol 8 (49) ◽  
pp. 3671-3674
Author(s):  
Aparna Prasanna Patange ◽  
Pavan Dahyabhai Patel ◽  
Shruti Shrinivas Nair ◽  
Dahyabhai Muljibhai Patel ◽  
Amit Botre ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-7
Author(s):  
Fumika Honma ◽  
Yoshihide Fujigaki ◽  
Yoshikazu Nemoto ◽  
Hirotoshi Kikuchi ◽  
Michito Nagura ◽  
...  

A 51-year-old woman with rheumatoid arthritis presented with mild hypertension 20 months after tacrolimus treatment and developing proteinuria 24 months after the treatment. Tacrolimus was discontinued 27 months after the treatment, followed by heavy proteinuria, accelerated hypertension, and deteriorating renal function without ocular fundus lesions as a clinical sign of malignant hypertension. Renal biopsy revealed malignant nephrosclerosis characterized by subacute and chronic thrombotic microangiopathy (TMA), involving small arteries, arterioles, and glomeruli. Focal segmental glomerulosclerosis, probably secondary to chronic TMA, was identified as a cause of heavy proteinuria. The zonal tubulointerstitial injury caused by subacute TMA may have mainly contributed to deteriorating renal function. The presence of nodular hyalinosis in arteriolar walls was indicative of tacrolimus-associated nephrotoxicity. Together with other antihypertensive drugs, administration of aliskiren stabilized renal function with reducing proteinuria. Owing to the preexisting proteinuria prior to severe hypertension and the complex renal histopathology, we postulated that chronic TMA, which was initially triggered by tacrolimus, was aggravated by severe hypertension, resulting in overt renal TMA.


2019 ◽  
Vol 12 (2) ◽  
pp. bcr-2017-223415 ◽  
Author(s):  
Nandakrishna Bolanthakodi ◽  
Sudha Vidyasagar ◽  
Muralidhar Varma ◽  
Avinash Holla

Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiological entity described by Hinchey et al in late 90’s, characterised by variable associations of seizure activity, consciousness impairment ranging from confusion to coma, headaches, visual abnormalities, nausea/vomiting and focal neurological signs. Common causes are accelerated hypertension, eclampsia, preeclampsia, cytotoxic drug use and autoimmune diseases like systemic lupus erythematosus.We report a case of PRES in a 62-year-old female patient due to hypercalcemia secondary to vitamin D toxicity on treatment with calcium supplements and vitamin D for secondary hypoparathyroidism. She had seizures and visual defects on presentation which recovered completely with treatment of hypercalcemia.


2018 ◽  
Vol 315 (5) ◽  
pp. R915-R924 ◽  
Author(s):  
Amrita V. Pai ◽  
Crystal A. West ◽  
Aline M. A. de Souza ◽  
Xi Cheng ◽  
David A. West ◽  
...  

Inbred salt-sensitive (SS) rats developed by John Rapp and distributed by Harlan (SS/JrHsd) were shown to model ovariectomy-induced hypertension because on a low-sodium (LS) diet, ovariectomized SS (SS-OVX) animals became hypertensive in contrast to their sham-operated (SS-SHAM) normotensive littermates. After Harlan merged with Envigo in 2015, inconsistencies in the LS normotensive phenotype were reported. To further investigate these inconsistencies, we studied the effects of ovariectomy on SS and salt-resistant (SR) rats purchased from Envigo (SS/JrHsd/Env) between 2015 and 2017. The mean arterial pressure (MAP) in SS rats on a LS diet exceeded 160 mmHg at 7 mo old. Ovariectomy at 3 mo had no detectable effect on MAP from 4 to 7 mo, nor did ovariectomy at 1.5 mo significantly affect MAP at 10 mo in either strain; only strain differences in MAP were observed [MAP: SR-SHAM ( n = 7 rats), 102 ± 3 mmHg; SR-OVX ( n = 6 rats), 114 ± 1 mmHg; SS-SHAM ( n = 7 rats), 177 ± 6 mmHg; SS-OVX ( n = 5 rats), 190 ± 12 mmHg; where P < 0.0001 vs. SR, same ovarian-status for SS-SHAM and SS-OVX, respectively]. Whole genome sequencing revealed more genomic variants of SS/JrHsd/Env, including single nucleotide and insertion deletion polymorphisms and higher heterozygous/homozygous ratios compared with the reference genome, than for SS/JrHsd/Mcwi and SS/Jr rats maintained in Milwaukee, WI and Toledo, OH, respectively, and which still exhibit normal blood pressure on a LS diet. These findings demonstrate that the female SS/JrHsd/Env rat has genetically diverged from the original phenotype, which was normotensive on a LS diet when the ovaries were intact but rapidly developed hypertension when the ovaries were removed. Nonetheless, the SS/JrHsd/Env rat could be a valuable model that complements other animal models of spontaneous hypertension used to investigate mechanisms of essential hypertension.


2018 ◽  
Vol 38 (5) ◽  
pp. 564-565 ◽  
Author(s):  
Elisa Pereira Pérez ◽  
María Dolores Sánchez de la Nieta García ◽  
Lucía González López ◽  
Francisco Rivera Hernández

Nefrología ◽  
2018 ◽  
Vol 38 (5) ◽  
pp. 564-565
Author(s):  
Elisa Pereira Pérez ◽  
María Dolores Sánchez de la Nieta García ◽  
Lucía González López ◽  
Francisco Rivera Hernández

Sign in / Sign up

Export Citation Format

Share Document